Month: May 2020

Vaccinex Reports First Quarter 2020 Financial Results and Provides Corporate Update

Written by Customer Service on May 14, 2020. Posted in Public Companies.

Approaching key topline data in non-small cell lung cancer and Huntington’s diseaseAdvancing plans to expand pepinemab development to include Alzheimer’s diseaseROCHESTER, N.Y., May 14, 2020 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and Huntington’s disease, today announced financial results for the first quarter ended March 31, 2020 and provided a corporate update.First Quarter and Recent Accomplishments:Presented updated interim data from the CLASSICAL-Lung Phase 1b/2 study of the company’s lead product candidate, pepinemab, in combination with avelumab (BAVENCIO®) in non-small cell lung cancer (NSCLC) at the American Association for Cancer Research Virtual Annual Meeting.Delivered three oral presentations highlighting...

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

Written by Customer Service on May 14, 2020. Posted in Public Companies.

PORTLAND, Maine, May 14, 2020 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (the “Company” or “ImmuCell”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef calves, today announced a change in the location of its 2020 Annual Meeting of Stockholders. In light of the COVID-19 pandemic and in an effort to protect the health and safety of the Company’s stockholders, employees and communities, the Annual Meeting will be held by remote communication in the form of both a dial-in conference call and an audio webcast rather than an in-person event.The Annual Meeting will take place Wednesday, June 10, 2020, at 3:00 PM ET, as previously announced. Stockholders of record of the Company’s common stock at the...

IDEX Biometrics – Report for the first quarter of 2020

Written by Customer Service on May 14, 2020. Posted in Public Companies.

The report is enclosed in pdf file.IDEX 2020 Q1 report pubCEO Vince Graziani and CFO Derek D’Antilio will hold a conference call at 15:00 CET today.Norway: +47 2350 0243Sweden: +46 8566 42651United Kingdom: +44 3333 000804United States: +1 631 913 1422Confirmation code: 16628677Report highlights:» IDEX continues to see significant progress in the biometric payment card market and the global Covid-19 pandemic has accelerated the need for a completely contactless solution.» Vince Graziani joined IDEX as CEO on February 27, 2020. The company expects to benefit from his considerable experience driving sales, strategic partnerships, and growth in technology companies.» IDEX’s technology has been certified by two major global payment networks; China UnionPay and a large US based network. These two...

BASi Releases Earnings for Second Quarter of Fiscal 2020

Written by Customer Service on May 14, 2020. Posted in Public Companies.

WEST LAFAYETTE, Ind., May 14, 2020 (GLOBE NEWSWIRE) — Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced financial results for the three months ended March 31, 2020.During the second quarter of fiscal 2020, BASi saw significant growth compared to the second quarter of fiscal 2019. Growth initiatives including acquisitions of the Gaithersburg, Maryland, operations of Smithers Avanza in May 2019 and Pre-Clinical Research Services, Inc’s. (“PCRS”) business in Ft. Collins, Colorado, in December 2019, as well as expansion of the Evansville facility and investment in the St. Louis facility, contributed to the increase in service revenue and gross margins. Over the last six months, we have...

TRACON Pharmaceuticals Announces Presentation of Positive Clinical Data for Envafolimab in MSI-H/dMMR Cancer at ASCO 2020 Virtual Scientific Program by its Corporate Partners 3D Medicines and Alphamab

Written by Customer Service on May 14, 2020. Posted in Public Companies.

Envafolimab Demonstrated a 30% Confirmed Objective Response Rate (ORR) by RECIST by Independent Central Review in Patients with Advanced Refractory MSI-H/dMMR Colorectal and Gastric CancerORR and Other Data will be Updated at ASCOTRACON Expects to Initiate its Pivotal ENVASARC Trial of Envafolimab in Sarcoma in Second Half of 2020SAN DIEGO, May 14, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced that positive data from envafolimab in a pivotal trial in China for the treatment of MSI-H/dMMR cancer will...

CSP Inc. Reports Fiscal Year 2020 Second Quarter Financial Results

Written by Customer Service on May 14, 2020. Posted in Earnings Releases And Operating Results.

LOWELL, Mass., May 14, 2020 (GLOBE NEWSWIRE) — CSP Inc. (NASDAQ: CSPI), a provider of security and packet capture products, managed IT and professional services and technology solutions, reported financial results for the 2020 fiscal second quarter ended March 31, 2020 and provided a business update.“Our team was performing well during the second quarter and meeting our expectations prior to the COVID-19 pandemic,” commented Victor Dellovo, Chief Executive Officer. “To minimize the business disruption, we quickly adjusted our operations to comply with local and federal requirements and currently over 90% of the team is working remotely, which allows us to maintain contact with customers. Despite the current environment we are continuing to experience a growing interest in our newest offerings, ARIA and Unified-Communications-as-a-Service...

Pan Orient Energy Corp.: 2020 First Quarter Financial & Operating Results

Written by Customer Service on May 14, 2020. Posted in Earnings Releases And Operating Results.

CALGARY, Alberta, May 14, 2020 (GLOBE NEWSWIRE) — Pan Orient Energy Corp. (“Pan Orient” or the “Company”) (POE – TSXV) reports 2020 first quarter consolidated financial and operating results. Please note that all amounts are in Canadian dollars unless otherwise stated, BOPD refers to barrels of oil per day and BOPD for Thailand operations represents volumes net to Pan Orient’s 50.01% equity interest in the Thailand Joint Venture.The Company is today filing its unaudited consolidated financial statements as at and for the three months ended March 31, 2020 and related management’s discussion and analysis with Canadian securities regulatory authorities. Copies of these documents may be obtained online at www.sedar.com or the Company’s website, www.panorient.ca.Commenting today on Pan Orient’s 2020 first quarter results, President and...

Diana Shipping Inc. Reports Financial Results For the First Quarter Ended March 31, 2020

Written by Customer Service on May 14, 2020. Posted in Earnings Releases And Operating Results.

ATHENS, Greece, May 14, 2020 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership of dry bulk vessels, today reported a net loss and net loss attributed to common stockholders of $102.8 million and $104.3 million for the first quarter of 2020, including a $93.1 million impairment loss. This compares to net income of $3.0 million and net income attributed to common stockholders of $1.5 million reported in the first quarter of 2019, including a $4.8 million impairment loss. Loss per share for the first quarter of 2020 was $1.21 compared to earnings per share of $0.02 for the same period in 2019. Adjusted loss per share, excluding impairment loss, was $0.13 for the quarter compared to adjusted earnings per share of $0.07 for the same quarter last year.Time charter...

Bragg Gaming Group Announces Time Change for its Full-Year 2019 Earnings Conference Call

Written by Customer Service on May 14, 2020. Posted in Public Companies.

TORONTO, May 14, 2020 (GLOBE NEWSWIRE) — Bragg Gaming Group Inc. (TSXV: BRAG, OTC: BRGGF) (“Bragg”) today announced that, due to unforeseen circumstances outside of the Company’s control, they will be adjusting the time of their scheduled FY 2019 earnings conference call. The call, originally scheduled for 8:30am EST today, will now take place at 4:30pm EST today, May 14th.The dial-in information will remain the same.To join the call, please use the below dial-in information:US/Canada: +1 270 215 9892US/Canada (toll-free): +1 866 997 6681UK: 0 800 917 4860Passcode: 9792139A replay of the call will be available for 7 days following the conclusion of the live call. In order to access the replay, dial +1 404 537 3406 or +1 855 859 2056 (toll-free) and use the passcode 9792139.About Bragg Gaming GroupBragg Gaming Group Inc. (TSXV:BRAG,...

ViralClear Publishes in F1000 Research In Vitro Data Demonstrating Synergy between Merimepodib and Remdesivir Against SARS-CoV-2, the Cause of COVID-19

Written by Customer Service on May 14, 2020. Posted in Public Companies.

Westport, CT, May 14, 2020 (GLOBE NEWSWIRE) —Merimepodib in combination with remdesivir decreases viral production of SARS-CoV-2 to undetectable levels in pre-clinical testing. Even at low concentrations of both drugs significant reduction in viral production occurs.Article highlights recent work done in laboratory studies of COVID-19 with merimepodib at the Galveston National Laboratory at The University of Texas Medical BranchBioSig Technologies, Inc. (Nasdaq: BSGM) today announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination with the adenosine analogue remdesivir reduces SARS-CoV-2 replication to undetectable levels in vitro” was published by F1000 Research, an online peer-reviewed life sciences journal publishing program in biology and medicine, while it is undergoing peer review.This manuscript...

Month: May 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals